Sevirumab. Protovir, MSL 109, EV2 7, SDZ MSL 109.

Sevirumab. Protovir, MSL 109, EV2 7, SDZ MSL 109. [electronic resource] - Drugs in R&D Nov 1999 - 315-7 p. digital

Publication Type: Journal Article

1174-5886

10.2165/00126839-199902050-00008 doi


Animals
Antibodies, Monoclonal--pharmacokinetics
Antiviral Agents--therapeutic use
Bone Marrow Transplantation--adverse effects
Clinical Trials, Phase I as Topic
Clinical Trials, Phase II as Topic
Cytomegalovirus--drug effects
Cytomegalovirus Infections--prevention & control
Cytomegalovirus Retinitis--drug therapy
Drugs, Investigational--pharmacokinetics
Humans
Microbial Sensitivity Tests
Rabbits